Hirudoid

Hirudoid is a topical gel that contains the active ingredient chondroitin polysulfate, a heparinoid classified as a topical antithrombotic. The product is marketed in the European Union and is available over the counter. Formulated as a skin‑applied gel, Hirudoid is designed to improve microcirculation and reduce localized swelling, bruising, and inflammation. It is intended for external use on intact or mildly damaged skin and is supplied in a non‑sterile container.

Hirudoid gel is commonly applied to the skin for several localized conditions where blood flow and swelling are concerns.

- Minor bruises (contusions) resulting from everyday injuries. - Superficial thrombophlebitis affecting small veins near the skin surface. - Hematomas or localized collections of blood under the skin. - Post‑traumatic swelling following sprains, strains, or minor surgical procedures. - Edema associated with venous stasis in the lower extremities.

Adverse skin reactions have been reported with topical chondroitin polysulfate, although most are mild and reversible.

Common: - Transient redness at the application site, typically resolving within a few hours. - Mild itching or tingling sensation that subsides with continued use. - Slight skin dryness or peeling localized to the treated area. - Temporary increase in local warmth without systemic fever.

Serious: - Allergic contact dermatitis presenting with blistering and intense itching. - Severe urticaria or widespread rash that may require medical evaluation. - Persistent swelling or pain extending beyond the area of application. - Rare cases of skin necrosis or ulceration requiring discontinuation.

When using Hirudoid gel, certain precautions help minimize risks and ensure appropriate use.

- Apply only to intact or mildly damaged skin; avoid open wounds or severe burns. - Do not use on mucous membranes, eyes, or genital areas. - Limit application to the recommended surface area and avoid excessive layering. - Discontinue use and seek medical advice if signs of allergic reaction develop. - Keep the product out of reach of children; accidental ingestion may cause gastrointestinal upset. - Store at room temperature, protected from direct sunlight and moisture. - Consult a healthcare professional before use during pregnancy or lactation, as safety data are limited.

Topical chondroitin polysulfate may interact with other agents applied to the skin or systemic anticoagulants.

Avoid: - Concurrent use with other topical heparinoids or anticoagulant creams, which may increase bleeding risk. - Application over areas treated with strong irritants or chemical peels. - Use on skin already exposed to high‑dose corticosteroid preparations.

Use with caution: - Systemic anticoagulant or antiplatelet medications (e.g., warfarin, aspirin) if large skin areas are treated. - Herbal or homeopathic topical products that may affect skin integrity. - Occlusive dressings that trap the gel and enhance absorption.